Treatment of early‐stage mycosis fungoides: results from the PROspective Cutaneous Lymphoma International Prognostic Index (PROCLIPI) study*-Reference-Cited by-同舟云学术

Treatment of early‐stage mycosis fungoides: results from the PROspective Cutaneous Lymphoma International Prognostic Index (PROCLIPI) study*

Published:2021-02-18 Issue:4 Volume:184 Page:722-730
ISSN:0007-0963
Container-title:British Journal of Dermatology
language:en
Short-container-title:Br J Dermatol

Author:

Quaglino P.¹^ORCID,Prince H.M.²,Cowan R.³,Vermeer M.⁴,Papadavid E.⁵,Bagot M.⁶,Servitjie O.⁷,Berti E.⁸,Guenova E.⁹^ORCID,Stadler R.¹⁰,Querfeld C.¹¹,Busschots A.M.¹²,Hodak E.¹³,Patsatsi A.¹⁴,Sanches J.¹⁵,Maule M.¹⁶,Yoo J.¹⁷,Kevin M.¹⁷,Fava P.¹,Ribero S.¹,Zocchi L.¹,Rubatto M.¹,Fierro M.T.¹,Wehkamp U.¹⁸,Marshalko M.¹⁹,Mitteldorf C.²⁰,Akilov O.²¹,Ortiz‐Romero P.²²,Estrach T.²³,Vakeva L.²⁴,Enz P.A.²⁵,Wobser M.²⁶,Bayne M.²⁷,Jonak C.²⁸,Rubeta M.²⁹,Forbes A.³⁰,Bates A.³¹,Battistella M.⁶,Amel‐Kashipaz R.¹⁷,Vydianath B.¹⁷,Combalia A.²³,Georgiou E.¹⁴,Hauben E.¹²,Hong E.K.³²,Jost M.¹⁸,Knobler R.²⁸,Amitay‐Laish I.¹³,Miyashiro D.¹⁵,Cury‐Martins J.¹⁵,Martinez X.¹¹,Muniesa C.⁷,Prag‐Naveh H.¹³,Stratigos A.⁵,Nikolaou V.⁵,Quint K.⁴,Ram‐Wolff C.⁶,Rieger K.³²,Stranzenbach R.¹⁰,Szepesi Á.¹⁹,Alberti‐Violetti S.⁸,Felicity E.¹⁷,Cerroni L.³³,Kempf W.³⁴,Whittaker S.³⁵,Willemze R.⁴,Kim Y.³²,Scarisbrick J.J.¹⁷³⁶

Affiliation:

1. Dermatologic Clinic University of Turin Medical School Turin Italy

2. Sir Peter MacCallum Department of Oncology University of Melbourne Melbourne VIC Australia

3. Christie Hospital Manchester UK

4. Leiden University Medical Centre Leiden the Netherlands

5. Athens University Medical School Athens Greece

6. Hospital St Louis Paris France

7. Hospital Universitari de Bellvitge Barcelona Spain

8. University of Milano Milan Italy

9. University Hospital Zurich Zurich Switzerland

10. Johannes Wesling University Medical Centre Minden Germany

11. City of Hope National Medical Center and Beckman Research Institute Duarte CA USA

12. Belgium University Hospitals Leuven Leuven Belgium

13. Rabin Medical Center Tel Aviv University Tel Aviv Israel

14. Aristotle University of Thessaloniki in Papageorgiou General Hospital Thessaloniki Greece

15. University of São Paulo Medical School São Paulo SP Brazil

16. Cancer Epidemiology Unit Department of Medical Sciences University of Turin Turin Italy

17. University Hospitals Birmingham Birmingham UK

18. University Hospital Schleswig‐Holstein Campus Kiel Kiel Germany

19. Semmelweis University Budapest Hungary

20. HELIOS Klinikum Hildesheim GmbH University Medical Center Göttingen Göttingen Germany

21. University of Pittsburgh School of Medicine Pittsburgh PA USA

22. Hospital 12 de Octubre Madrid Spain

23. Hospital Clinico University of Barcelona Barcelona Spain

24. Helsinki University Central Hospital Helsinki Finland

25. Hospital Italiano De Buenos Aires Buenos Aires Argentina

26. University Hospital Wuerzburg Wuerzburg Germany

27. Poole Hospital Poole UK

28. Department of Dermatology Medical University of Vienna Vienna Austria

29. Churchill Hospital Oxford University Hospitals NHS Foundation Trust Oxford UK

30. Torbay Hospital Torbay UK

31. University Hospital Southampton Southampton UK

32. Stanford University Stanford CA USA

33. Department of Dermatology, Research Unit Dermatopathology Medical University of Graz Graz Austria

34. Kempf und Pfaltz Histologische Diagnostik Zurich Switzerland

35. Kings College London Guy's and St Thomas’ NHS Foundation Trust London UK

36. European Co‐ordinating PROCLIPI Centre for PROCLIPI University Hospitals Birmingham Birmingham UK

Funder

Cancer Research UK

Krebsliga Schweiz

Promedica Stiftung

Publisher

Wiley

Subject

Dermatology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/bjd.19252

Reference34 articles.

1. The 2018 update of the WHO-EORTC classification for primary cutaneous lymphomas

2. Defining early mycosis fungoides

3. Survival Outcomes and Prognostic Factors in Mycosis Fungoides/Sézary Syndrome: Validation of the Revised International Society for Cutaneous Lymphomas/European Organisation for Research and Treatment of Cancer Staging Proposal

4. Time course, clinical pathways, and long-term hazards risk trends of disease progression in patients with classic mycosis fungoides

5. Long-term Outcomes of 1,263 Patients with Mycosis Fungoides and Sézary Syndrome from 1982 to 2009

Cited by 47 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Predictors for the use of systemic therapy in stage IB Mycosis fungoides;Archives of Dermatological Research;2024-06-06

2. Effectiveness of narrowband ultraviolet B monotherapy versus combination therapy with systemic agents in patients with early‐stage mycosis fungoides and the association with plaque lesions;Journal of Evidence-Based Medicine;2024-06

3. Advances in the pharmacological management of cutaneous T-cell lymphoma;Expert Opinion on Pharmacotherapy;2024-05-02

4. Risk of progression of early-stage mycosis fungoides, 10-year experience;Anais Brasileiros de Dermatologia;2024-05

5. The Impact of Primary Tumor Site on Survival in Mycosis Fungoides;Cutis;2024-04-01